title: Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea.
authors.affiliation: Hematology and ABMT Unit, Ospedale S. Martino, Genoa, Italy.
authors.forename: A M
authors.initials: AM
authors.lastname: Carella
authors.forename: F
authors.initials: F
authors.lastname: Frassoni
authors.forename: N
authors.initials: N
authors.lastname: Pollicardo
authors.forename: E
authors.initials: E
authors.lastname: Pungolino
authors.forename: M
authors.initials: M
authors.lastname: Podestà
authors.forename: D
authors.initials: D
authors.lastname: Giordano
authors.forename: R
authors.initials: R
authors.lastname: Ferrero
authors.forename: M
authors.initials: M
authors.lastname: Soracco
authors.forename: F
authors.initials: F
authors.lastname: Benvenuto
authors.forename: O
authors.initials: O
authors.lastname: Figari
mesh_terms: D002469:Cell Separation; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics; D010677:Philadelphia Chromosome
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D006918:Hydroxyurea